BIO-Europe Copenhagen’s Startup Slam Winner 2018: SunRegen Healthcare AG

---

August 8, 2025

SunRegen Healthcare was announced as the winner of the BIO-Europe® 2018 Startup Slam competition, held in Copenhagen. Dr Yuhong Dong, Director and co-founder of SunRegen presented on how the company’s therapeutic a potentially transformative healthcare solution for neurodegenerative eye diseases. SunRegen receives a complimentary registration to BIO-Europe Spring® 2019 in Vienna, plus access to a top-tier mentoring program with industry experts from Johnson & Johnson Innovation. Additionally, REVision Therapeutics, focused on repurposed drugs for the treatment of ophthalmic diseases, was selected for the inaugural Audience Choice award.

More details are published in:

https://www.prnewswire.com/news-releases/bio-europe-copenhagen-s-startup-slam-winner-2018-sunregen-healthcare-ag-843362853.html

SunRegen Wins Startup Slam at BIO-Europe 2018, proving the company leads in ophthalmic therapeutics. Moreover, the award highlights SunRegen’s innovative approach and its potential to improve patient care.

The company actively collaborates with global experts to develop treatments for neurodegenerative eye diseases. In addition, SunRegen shares its research through conferences, publications, and workshops. These efforts demonstrate the team’s dedication to advancing eye health.

For more insights, explore our pages on Neurodegenerative Eye Disease Treatments and SunRegen Research Updates.

Furthermore, winning the BIO-Europe Startup Slam has opened doors for new collaborations and strengthened SunRegen’s credibility in the biotech community. As a result, this recognition highlights the company’s ongoing commitment to improving patient outcomes through innovative therapies. Additionally, by actively collaborating with experts and participating in international events, SunRegen delivers impactful solutions for eye health.